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Conclusions: The initial results of GPBA and CBA wars satisfactory compared to those 
of POBA, due to less dissections and elastic recoil. 6-month results of GPBA were favor- 
able and similar to those of CBA, suggesting that both GP,BA and CBA were more effec- 
tive in cases with small coronary arteries compared to POBA. 
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Introduction: In 1997 the German Cardiac Society set up a registry to evaluate the acute 
and mid-term course of all patients (pts.) treated with septal ablation for symptomatic 
hypertrophic obstructive cardiomyopathy (HOCM). An analysis of the acute results has 
already been published (Eur. Heart J. 2000, 21, 413). We now reporl on the mid-term 
course (3-6 months) of pts. registered before September 1999. 
Results: Follow-up was 92% complete (n=222/242). In addition to the in-hospital mortal- 
ity of 3 pts. (1.2%). 3 other pts. died during follow-up. Pts. who died had a siginificantly 
higher CK level (721~307 vs. 477*254 U/l; peO.05) and lower provokable outflow gradi- 
ents (LVOTG) at discharge (16r33 vs. 46*40 mm Hg, p=O.O6). Overall symptomatic 
improvement in the surviving pts. parallelled the reduction of left atrial (LA) diameter, sep- 
tal thickness and outflow gradients. 
Conclusion: Clinical success by septal ablation can be achieved in about 90% of highly 
symptomatic HOCM pts. During mid-term follow-up symptoms and outflow gradients are 
further improved as compared to the acute result. Analysis of 90 day mortality, however, 
suggests a cautious approach with respect to the intensity 01 acute LVOTG reduction, 
and to the creation of very large ablation lesions. 
Parameter baseline acute result follow-up result p-value 
NYHA functional class 2.6eO.7 1.6iO.6 1.7t0.7 <O.OOOl 
LA diameter (mm) 46+9 44r7 <O.OOOl 
Septal thickness (mm) 20*5 15*5 <0.0001 
LVOTG (rest, mm Hg) 57+31 23+25 Z&21 <O.cOOl 
LVOTG (stress, mm Hg) 106t53 47*40 44140 <O.OOOl 
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Background: Use of intraluminal sonotherapy (1 MHz) reduces intimal hyperplasia after 
stent deployment in animal models, but little data on the ability of sonotherapy prior to intra- 
coronary stent implantation to prevent rsstenosis in humans is available. Moreover, the 
effects of sonotherapy at the edges of the delivery source in regions that have not received 
balloon injury are unknown. Methods: Angiographic images were available on 93 patients 
enrolled to receive sonotherapy with Stent implantation for denovo coronary stenoses. We 
used quantitative angiography to assess lumen changes in several predetenined zones: 
within the stentsd segment; within the balloon “injured’ segment; within the ultrasound seg- 
ment, within the zones treated with sonotherapy, and at the 5 mm proximal and distal edge 
of the sonotherapy source. Resub Baseline lesion characteristics were similar to con- 
tsmpowy coronary stenting hials. At 6 month follow-up (data available on 64% of patients 
enmlled) the binary restenosis rate wfthin the stent, balloon injured and sonotherapy 
treated Segments was 16.7%, with only one additional patient exhibiiing restenosis in the 
analysis zone, beyond the area treated with sonotherapy. 
Laslon Characterlstlc 
Basellne 
Sonotherapy Treated Patients 
(N.93) 
Reference Vessel Diameter (mm) 2.66kO.46 
Minimal Lumen Diameter (mm) 0.85*0.44 
Percent Diameter Stenosis 70.3%il4.9% 
Post Procedure 
Reference Vessel Diameter (mm) 2.93M.45 
In-Stent Minimal Lumen Diameter (mm) 2.66M.44 
In-Stent Percent Diameter Stenosis 1.6%*10.6% 
Injured Segment Percent Diameter Stenosis 6.6%+12.4% 
Sonotherapy Segment Percent Diameter Stenosis 14.9%f12.6% 
Analysis Segment Percent Diameter Stenosis 16.1%f12.6% 
Follow-Up 
Reference Vessel Diameter (mm) 2.90zt0.52 
In-Stent Minimal Lumen Diameter (mm) 1.9OiO.73 
In-Stent Percent Diameter Stenosis 35.3%~1.3% 
Injured Segment Percent Diameter Stenosis 36.7%i20.6% 
Sonotherapy Segment Percent Diameter Stenosis 37.6%f19.5% 
Analysis Segment Percent Diameter Stenosis 36.7%+19.6% 
In-Stent Binary Restenosis Rate 16.7% (13i76) 
Injured Segment Binary Restenosis Rate 16.7% (13176) 
Sonotherapy Segment Binary Restenosis Rate 16.7% (13178) 
Analysis Segment Binary Restenosis Rate 17.9%(14/76) 
Conclusions: The use of sonotherapy prior to Stent implantation was associated with a 
favorable rsstenosis rate in this study. Additionally, there was no evidence of injury or 
increased restenosis in the vessel zones treated with sonotherapy only. 
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Background: Atrial fibrillation (AF) is the most common clinically significant chronic 
arrhythmia. It is associated wilh an adverse prognosis and increased morbidity and mor- 
tality. The outcome of patients with AF who undergo percutaneous coronary intervention 
(PCI) has not been well determined. Methods: Between 1195 and 3/2000, a total of 241 
consscutive patients with chronic AF underwent PCI at our institution. These patients 
were matched for age with 1,276 patients with normal sinus rhythm (NSR) who under- 
went PCI during the same time period. Results: Patients with AF were significantly more 
likely to have cardiovascular disease risk factors and preexisting disease at baseline, 
including hypertension, prior myocardial infarction, bypass surgery and lower left ventric- 
ular function. Despite similar angiographic success rates in both groups (>96%), in-hos- 
pital complications were more frequent in AF patients (pulmonary edema, acute renal 
failure and death)(Table). By multivariate analysis, AF was an independent predictor of 
long-term mortality (OR:r.7,Cl=O.96-3.03, p=O.O3). Conclusions: The presence of atrial 
fibrillation in patients who undergo PCI is associated with markedly reduced survival 
compared with patients without AF, with risk factor-adjusted odds ratio for death of 1.7. 
The multivariate analyses suggests that the greater mortality probably was atributable to 




Death (1 P-month) 
MACE (12-month) 
AF (n=241) NSR (n=l,278) P 
5.4 % 2.4 % 0.07 
5.6 % 3.3 % 0.06 
16.6 % 6.6 % <0.001 
24.6 % 17.4 % 0.04 
